152 related articles for article (PubMed ID: 4040986)
21. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy of recombinant human leukocyte A interferon (rIFN-alpha A) on malignant tumors of the urogenital tract].
Gan To Kagaku Ryoho; 1985 Apr; 12(4):921-7. PubMed ID: 3885863
[TBL] [Abstract][Full Text] [Related]
23. [Effects of etoposide in testicular tumors].
Tanahashi T; Matsumura Y; Ozaki Y; Yoshimoto J; Tsushima T; Obama T; Akagi T; Nasu Y; Ohmori H
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3074-7. PubMed ID: 3767390
[TBL] [Abstract][Full Text] [Related]
24. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
Machida T; Koiso K; Takaku F; Ogawa M
Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
[TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.
Vaughn CB; Panettiere F; Thigpen T; Bottomley R; Hoogstraten B; Samal B
Cancer Treat Rep; 1981; 65(5-6):443-5. PubMed ID: 7237465
[No Abstract] [Full Text] [Related]
26. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
27. [Phase II study of VP-16 (capsule) in solid tumors. A cooperative study].
Honma T; Ogawa M; Yoshida S; Meguro S; Hirano M; Hoshino A; Shirakawa S; Nakamura T; Fukuoka M; Toki H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):309-13. PubMed ID: 2982332
[TBL] [Abstract][Full Text] [Related]
28. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
Koyama H; Adachi I; Tajima T; Kanda K; Yoshida M; Miura S; Nakao K; Kikkawa N; Takai S; Toge T; Tamura K; Inaji H; Shiba E
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
[TBL] [Abstract][Full Text] [Related]
29. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
[TBL] [Abstract][Full Text] [Related]
30. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
Nakada H; Ogawa M; Ingaki J; Horikoshi N; Inoue K; Usui N; Adachi K; Tada A; Yamazaki H; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1644-8. PubMed ID: 6476837
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of etoposide for carcinoma of the prostate.
Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
[TBL] [Abstract][Full Text] [Related]
32. [Phase II study of CIS-diamminedichloroplatinum (II) by collaborative study].
Kato T
Gan To Kagaku Ryoho; 1982 Apr; 9(4):694-701. PubMed ID: 6892198
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of etoposide in advanced prostate cancer.
Trump DL; Loprinzi CL
Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
[No Abstract] [Full Text] [Related]
34. Oral VP-16-213 in transitional cell carcinoma of the bladder: a phase II study.
Panduro J; Hansen M; Hansen HH
Cancer Treat Rep; 1981; 65(7-8):703-4. PubMed ID: 7248987
[No Abstract] [Full Text] [Related]
35. [Phase I clinical study of 21-consecutive-day oral administration of etoposide].
Noda K; Fukuoka M; Komatsu H; Hayashihara K; Ariyoshi Y; Tanaka K; Nakajima H; Terashima Y; Nagao K; Furuse K
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1633-9. PubMed ID: 8060139
[TBL] [Abstract][Full Text] [Related]
36. Oral etoposide in gestational trophoblastic disease.
Wong LC; Choo YC; Ma HK
Cancer Treat Rep; 1984 May; 68(5):775-7. PubMed ID: 6327035
[TBL] [Abstract][Full Text] [Related]
37. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
38. [Phase II study of UFT for malignant tumors of urinary organs].
Shida K; Yamanaka H; Ito Y; Shimazaki J; Isaka S; Yokokawa M; Fukui I; Kawai H; Akimoto M; Yoshida K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1307-14. PubMed ID: 6428325
[TBL] [Abstract][Full Text] [Related]
39. Phase II clinical trial of VP-16-213 in ovarian cancer.
Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
[No Abstract] [Full Text] [Related]
40. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]